Glenmark Pharmaceuticals has informed that it has attached media release on 11th February 2021, titled ‘Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Gel USP, 1%’ which is self?explanatory.
The above information is a part of company’s filings submitted to BSE.